Registration - Organization
Servier Canada Inc. / Lucie Rousseau, General Manager
Registration Information
Senior Officer Name: Lucie Rousseau, General Manager
Senior Officer Change History
Initial registration start date: 2014-12-02
Registration status: Active
Projected end date: No date provided
Registration number: 9375-2682
Associated Lobbying Activity Reports
Total number of Lobbying Activity Reports: 0
Lobbying Activity Reports - last 6 months: 0
Version 17 of 19 (2023-01-16 to 2024-04-01)
Version 17 of 19 (2023-01-16 to 2024-04-01)
Lobbying Information
Details Regarding the Identified Subject Matter |
||||||||||
| Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below: | No | |||||||||
|
||||||||||
BC Ministries/Provincial Entities
- Health
Organization Details
Senior Officer Name and Position during the Period of this Registration
Lucie Rousseau, Director, Operations
Organization Contact Information
Servier Canada Inc.
Address:
#270 - 3224 avenue Jean-Béraud
Laval, QC H7T 2S4
Canada
Telephone number:
514-296-6064
Description of Activities
Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, an international pharmaceutical company governed by a non-profit foundation, with its global headquarters in France (Suresnes), specializing in ethical pharmaceuticals. With a strong international presence in 149 countries employing more than 21,700 people worldwide, Servier Research Group is entirely independent and reinvests 25% of its turnover from innovative therapies back in to research and development. The mission of Servier Canada is to provide the Canadian medical community and their patients with innovative therapeutic solutions in different therapeutic areas of high unmet needs, like cardiology, diabetes and oncology. Servier Canada collaborates with various stakeholders including researchers, biotech entrepreneurs and innovators. In addition to these partnerships, the Center of Excellence in Clinical Research of Servier Canada is dedicated to clinical development. Servier will not only have innovative new products in its existing therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. Recently, Servier Canada has received approval for 3 new agents. In the future, Servier Canada will add to the portfolio by making new products available for: the prevention of cardiovascular events, type 2 diabetes, depression, mild cognitive impairment and oncology. For more information please consult : www.servier.ca
Gifts or benefits provided by the organization
| Name | Gift or Benefit Description | Circumstance | Date Promised | Value Promised | Date Given | Value Given |
|---|---|---|---|---|---|---|
| No Records | ||||||
Contributors to the Lobbying Activity
No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.
Government Funding in the Last 12 Months
No government funding was requested or received within the preceding 12 months.Coalition Members Information
Servier Canada Inc. is not a coalition member.
Affiliates with a Direct Interest in the Outcome
- BioFarma S.A
-
50 Rue Carnot,Suresnes, Cedex, France 92284
Suresnes 92284
France
-
50 Rue Carnot,Suresnes, Cedex, France 92284
Other Persons or Organizations with Direct Interests
The activities of Servier Canada Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.
Lobbyists Details
| Lobbyist | Contributions | ||
|---|---|---|---|
|
Raffi Merdkhanian Subscribes to a Code of Conduct: No Former Public Office Holder in BC: No |
|
||
|
Lucie Rousseau Subscribes to a Code of Conduct: No Former Public Office Holder in BC: No |
|
- Date Modified: